Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — President Biden promised Monday that Democrats’ signature drug pricing plan will mean no insured American will spend more than $35 per month for insulin. Drug pricing advocates say that’s not good enough — they’re pushing for last-minute changes to expand those reforms to the uninsured.

Democrats’ drug pricing reforms, which are included in the larger spending package known as the Build Back Better Act, would cap how much those with insurance can pay out of pocket each month for insulin at $35. The provision currently applies to those covered by both Medicare and private insurance, but it does not change how much those without insurance will pay for their insulin.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment